Page last updated: 2024-08-22

platinum and Lymphoproliferative Disorders

platinum has been researched along with Lymphoproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glaspy, J; Poulsen, E; Rossi, G; Vansteenkiste, J	1

Trials

1 trial(s) available for platinum and Lymphoproliferative Disorders

Article	Year
Darbepoetin alfa: impact on treatment for chemotherapy-induced anemia and considerations in special populations. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:10 Suppl 1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Darbepoetin alfa; Double-Blind Method; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoietin; Female; Hemoglobins; Humans; Lung Neoplasms; Lymphoproliferative Disorders; Male; Middle Aged; Platinum; Population Surveillance; Sex Factors; Treatment Outcome	2002

Article

Year

Darbepoetin alfa: impact on treatment for chemotherapy-induced anemia and considerations in special populations.

Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:10 Suppl 1

Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Darbepoetin alfa; Double-Blind Method; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoietin; Female; Hemoglobins; Humans; Lung Neoplasms; Lymphoproliferative Disorders; Male; Middle Aged; Platinum; Population Surveillance; Sex Factors; Treatment Outcome

2002